Santen Pharmaceutical Co., Ltd. (SNPHY)
11.78
-0.07
(-0.59%)
USD |
OTCM |
Aug 24, 16:00
Santen Pharmaceutical EPS Diluted (Quarterly) : 0.1399 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1399 |
| March 31, 2026 | 0.3043 |
| December 31, 2025 | 0.158 |
| September 30, 2025 | 0.1656 |
| June 30, 2025 | 0.1195 |
| March 31, 2025 | 0.1686 |
| December 31, 2024 | 0.1656 |
| September 30, 2024 | 0.1557 |
| June 30, 2024 | 0.1893 |
| March 31, 2024 | 0.0006 |
| December 31, 2023 | 0.1397 |
| September 30, 2023 | 0.1696 |
| June 30, 2023 | 0.2025 |
| March 31, 2023 | 0.0224 |
| December 31, 2022 | 0.1093 |
| September 30, 2022 | -0.5462 |
| June 30, 2022 | 0.1292 |
| March 31, 2022 | 0.1689 |
| December 31, 2021 | 0.1107 |
| September 30, 2021 | 0.158 |
| June 30, 2021 | 0.1685 |
| March 31, 2021 | -0.2755 |
| December 31, 2020 | 0.1746 |
| September 30, 2020 | 0.1794 |
| June 30, 2020 | 0.1438 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.0761 |
| December 31, 2019 | 0.1643 |
| September 30, 2019 | 0.1571 |
| June 30, 2019 | 0.1455 |
| March 31, 2019 | 0.1922 |
| December 31, 2018 | 0.1953 |
| September 30, 2018 | 0.1654 |
| June 30, 2018 | 0.1538 |
| March 31, 2018 | 0.1791 |
| December 31, 2017 | 0.2622 |
| September 30, 2017 | 0.1379 |
| June 30, 2017 | 0.1969 |
| March 31, 2017 | 0.0989 |
| December 31, 2016 | 0.1042 |
| September 30, 2016 | 0.1219 |
| June 30, 2016 | 0.1632 |
| March 31, 2016 | 0.0727 |
| December 31, 2015 | 0.1235 |
| September 30, 2015 | 0.7143 |
| June 30, 2015 | 0.1488 |
| March 31, 2015 | 0.129 |
| December 31, 2014 | 0.1548 |
| September 30, 2014 | 0.1303 |
| June 30, 2014 | 0.0964 |
| March 31, 2014 | 0.0409 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 0.2213 |
| Daiichi Sankyo Co., Ltd. | 0.2366 |
| Eisai Co., Ltd. | 0.1015 |
| Chugai Pharmaceutical Co., Ltd. | 0.2218 |
| Ono Pharmaceutical Co., Ltd. | 0.1075 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 45.18M |
| Revenue (Quarterly) | 432.73M |
| Total Expenses (Quarterly) | 387.58M |
| Enterprise Value | 3.487B |
| Gross Profit Margin (Quarterly) | 54.66% |
| Profit Margin (Quarterly) | 10.44% |
| Earnings Yield | 6.52% |
| Operating Earnings Yield | 7.62% |